Cargando…

The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen

Detalles Bibliográficos
Autores principales:	Breitner, John C. S, Martin, Barbara K, Meinert, Curtis L
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1713263/ https://www.ncbi.nlm.nih.gov/pubmed/17192795 http://dx.doi.org/10.1371/journal.pctr.0010041

Ejemplares similares

Clinical Pharmacology and Cardiovascular Safety of Naproxen
por: Angiolillo, Dominick J., et al.
Publicado: (2016)

Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis
por: Essex, Margaret Noyes, et al.
Publicado: (2014)

The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis
por: Falkner, B, et al.
Publicado: (2015)

Cardiovascular Safety of Naproxen for Treating Cancer and Noncancer Chronic Pain
por: Nair, Abhijit S
Publicado: (2019)

No apparent effect of naproxen on CSF markers of innate immune activation
por: Meyer, Pierre‐François, et al.
Publicado: (2019)

Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)

Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial
por: Chirikov, Viktor V, et al.
Publicado: (2021)

Concerning the Growth Failure during Lung Function Development: Beyond the Evaluation
por: Guo, Yi, et al.
Publicado: (2023)

Concerns about medical abuses against Uighurs in China
por: Curtis, David
Publicado: (2021)

Ayurveda formulations: A roadmap to address the safety concerns
por: Rastogi, Sanjeev
Publicado: (2018)

Photoallergy to Naproxen
por: Rojas Perez-Ezquerra, Patricia, et al.
Publicado: (2021)

INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019)

The Co-Administration of COVID-19 and Hepatitis B Vaccines, Should Safety Be a Concern?
por: Alrashdan, Mohammad S., et al.
Publicado: (2022)

A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo
por: Cannon, Christopher P, et al.
Publicado: (2008)

Cardiovascular safety of celecoxib in acute myocardial infarction patients: a nested case-control study
por: Vanasse, Alain, et al.
Publicado: (2009)

Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis
por: Cheng, Bai-Ru, et al.
Publicado: (2021)

The status of clinical trials: Cause for concern
por: Nussenblatt, Robert B, et al.
Publicado: (2010)

The methanol sesquisolvate of sodium naproxen
por: Kriegner, Helene, et al.
Publicado: (2018)

Naproxen-Induced Evans Syndrome
por: Ahoussougbemey Mele, Ange, et al.
Publicado: (2023)

The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review
por: Ailani, Jessica, et al.
Publicado: (2023)

Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
por: Roberts, David N, et al.
Publicado: (2011)

Concerning the Wassermann Reaction
por: Venkataramaniah, G.
Publicado: (1944)

To Whom It May Concern
por: Butler, C. B., et al.
Publicado: (1869)

Development and Evaluation of a Reconstitutable Dry Suspension to Improve the Dissolution and Oral Absorption of Poorly Water-Soluble Celecoxib
por: Kim, Hye-In, et al.
Publicado: (2018)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

The Cunningham Panel: concerns remain
por: Bejerot, Susanne, et al.
Publicado: (2019)

Observations on CO(2) Laser Preparation of Recipient Site for Noncultured Cell Suspension Transplantation in Vitiligo
por: Komen, Lisa, et al.
Publicado: (2016)

Reply to comment on “Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis”
por: Gao, Linggen, et al.
Publicado: (2022)

Response to letter to the editor “Should women have lower thresholds for hypertension diagnosis and treatment”
por: Meinert, Fabian, et al.
Publicado: (2023)

Preparation and In vitro Evaluation of Naproxen Suppositories
por: Hargoli, S., et al.
Publicado: (2013)

Recent Advances in the Synthesis of Ibuprofen and Naproxen
por: Ha, Min-Woo, et al.
Publicado: (2021)

Concerns about Direct Potable Reuse
por: Adelman, Brenda
Publicado: (2015)

Concerns regarding the reliability of subgroup effects
por: Qiu, Mei, et al.
Publicado: (2023)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Beyond 100 genomes
por: Janssen, Paul, et al.
Publicado: (2003)

Beyond Me, Too
por: Vaish, Richa, et al.
Publicado: (2016)

Beyond Viral Suppression
por: Behrens, Georg M N
Publicado: (2021)

Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
por: Sobolewski, Cyril, et al.
Publicado: (2021)

Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee
por: Zeng, Chao, et al.
Publicado: (2015)

COVID-19 and the liver: little cause for concern
por: Bangash, Mansoor N, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gro5iopfhnmfge9k311cuorupe